Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 10Pulmonary Embolism 4Venous Thrombosis 3Neoplasms 3Thrombosis 2Multiple Myeloma 2Urinary Bladder Neoplasms 1Thromboprophylaxis 1Thromboembolism 1Thrombocytopenia 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Fibrosis 1Embolism 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thromboprophylaxis × apixaban × 1 year × Clear all
NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting
1,456 enrolled

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡